68Ga-DOTA-NT-20.3
68Ga-DOTA-NT-20.3
Unknown other completed
Quick answer
68Ga-DOTA-NT-20.3 for Pancreatic Ductal Adenocarcinoma is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Pancreatic Ductal Adenocarcinoma
- Phase
- Unknown
- Modality
- other
- Status
- completed